Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells

Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance

(2011) H. ZENG et al.   NEOPLASMA

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Empowering induction therapy for locally advanced head and neck cancer

(2010) A. Argiris et al.   ANNALS OF ONCOLOGY

Optimal treatment for recurrent/metastatic head and neck cancer

(2010) J. B. Vermorken et al.   ANNALS OF ONCOLOGY

RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro

(2010) Bo Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

EMMPRIN expression in tongue squamous cell carcinoma

(2009) Zhiquan Huang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment

(2009) Shanthi Marur et al.   MAYO CLINIC PROCEEDINGS

Regulation of cell signalling by uPAR

(2009) Harvey W. Smith et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

(2008) A. P. Mazar   CLINICAL CANCER RESEARCH

Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma

(2008) François Janot et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Advances in Head and Neck Cancer

(2008) Robert I. Haddad et al.   NEW ENGLAND JOURNAL OF MEDICINE